Literature DB >> 18258252

Generation and characterization of an immunogenic dendritic cell population.

Stephan Gehring1, Stephen H Gregory, Philip Wintermeyer, Maryann San Martin, Costica Aloman, Jack R Wands.   

Abstract

Dendritic cells (DCs) capture, internalize and process antigens leading to the induction of antigen-specific immune responses. The aim of this study was to develop, implement and characterize an efficient approach for DC-based immunization. Dendritic cells were expanded in vivo by hydrodynamic delivery of a human flt3 ligand expression plasmid. Splenic DCs were isolated and purified with magnetic beads linked to hepatitis C virus (HCV) nonstructural protein-5 (NS5), anti-CD40 and/or LPS. The DCs that contained beads were purified by passage over a magnetic column and subsequently phenotyped. Enrichment resulted in a population consisting of 80% CD11c(+) cells. Uptake of uncoated microparticles promoted DC maturation and the expression of CD80, CD86, and MHC-II molecules; beads coated with LPS and anti-CD40 further increased the expression of these co-stimulatory molecules, as well as the secretion of IL-12. Mice immunized subcutaneously with DCs containing beads coated with HCV NS5 protein, anti-CD40 and LPS exhibited significant antigen-specific, increases in IFN-gamma-producing CD4(+) T cells and CTL activity. This approach combines three critical elements necessary for efficient DC-based immunization that include DC enrichment, maturation and antigen targeting.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18258252     DOI: 10.1016/j.jim.2007.12.007

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  7 in total

1.  Chronic alcohol-induced liver disease inhibits dendritic cell function.

Authors:  Dechun Feng; Ahmet Eken; Vivian Ortiz; Jack R Wands
Journal:  Liver Int       Date:  2011-03-21       Impact factor: 5.828

2.  Tumor progression-related transmembrane protein aspartate-β-hydroxylase is a target for immunotherapy of hepatocellular carcinoma.

Authors:  Masafumi Shimoda; Yoshito Tomimaru; Kevin P Charpentier; Howard Safran; Rolf I Carlson; Jack Wands
Journal:  J Hepatol       Date:  2012-01-13       Impact factor: 25.083

3.  Immunization with aspartate-β-hydroxylase-loaded dendritic cells produces antitumor effects in a rat model of intrahepatic cholangiocarcinoma.

Authors:  Takehiro Noda; Masafumi Shimoda; Vivian Ortiz; Alphonse E Sirica; Jack R Wands
Journal:  Hepatology       Date:  2012-01       Impact factor: 17.425

4.  Immune response of cytotoxic T lymphocytes and possibility of vaccine development for hepatitis C virus infection.

Authors:  Kazumasa Hiroishi; Junichi Eguchi; Shigeaki Ishii; Ayako Hiraide; Masashi Sakaki; Hiroyoshi Doi; Risa Omori; Michio Imawari
Journal:  J Biomed Biotechnol       Date:  2010-05-20

Review 5.  Hepatitis C virus and alcohol.

Authors:  Larry Siu; Julie Foont; Jack R Wands
Journal:  Semin Liver Dis       Date:  2009-04-22       Impact factor: 6.115

6.  Generation of immune responses against hepatitis C virus by dendritic cells containing NS5 protein-coated microparticles.

Authors:  Stephan Gehring; Stephen H Gregory; Philip Wintermeyer; Costica Aloman; Jack R Wands
Journal:  Clin Vaccine Immunol       Date:  2008-12-17

7.  Generation of cellular immune responses to HCV NS5 protein through in vivo activation of dendritic cells.

Authors:  P Wintermeyer; S Gehring; A Eken; J R Wands
Journal:  J Viral Hepat       Date:  2010-10       Impact factor: 3.728

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.